Congratulations to Chris Yankaskas, Kostas Konstantopoulos, and all of my co-authors on the publication of a study in Nature Biomedical Engineering showing that a microfluidic chip can be used to predict the metastatic propensity of a breast cancer cell sample! The study presents an elegant use of our patented microfluidic migration chip to offer a prediction about whether a population of cancer cells is likely to metastasize and characterize the properties of this highly metastatic subpopulation. Read a commentary about the study here.
0 Comments
Leave a Reply. |
AuthorColin Paul is a CRTA Fellow at the National Cancer Institute, National Institutes of Health. Archives
August 2019
Categories |